LAVALLE, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 908
EU - Europa 519
AS - Asia 160
AF - Africa 8
SA - Sud America 7
OC - Oceania 1
Totale 1.603
Nazione #
US - Stati Uniti d'America 895
IT - Italia 321
IN - India 69
SE - Svezia 57
SG - Singapore 55
BG - Bulgaria 29
DE - Germania 23
FI - Finlandia 23
CN - Cina 14
FR - Francia 13
RO - Romania 12
GB - Regno Unito 10
CA - Canada 9
IE - Irlanda 7
NL - Olanda 7
UA - Ucraina 7
AR - Argentina 6
HK - Hong Kong 6
TH - Thailandia 6
PL - Polonia 5
TG - Togo 5
EG - Egitto 3
PK - Pakistan 3
GR - Grecia 2
KR - Corea 2
MX - Messico 2
TR - Turchia 2
BZ - Belize 1
CL - Cile 1
DO - Repubblica Dominicana 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 1.603
Città #
Rome 127
Fairfield 115
Ashburn 111
Chandler 108
Wilmington 44
Princeton 43
San Paolo di Civitate 43
Woodbridge 39
Seattle 37
Houston 33
Sofia 29
Cambridge 28
Millbury 28
Lawrence 24
Singapore 22
Helsinki 21
San Diego 18
Milan 15
Andover 12
Pune 11
Ann Arbor 10
New York 10
Boston 9
Dublin 7
Amsterdam 6
Beijing 6
Bologna 6
Hong Kong 6
Redwood City 6
Toronto 6
Bühl 5
Catania 5
Federal 5
Lomé 5
Norwalk 5
San Mateo 5
Verona 5
Adelfia 4
Bari 4
Oxford 4
Reggio Emilia 4
Straubenhardt 4
Bremen 3
Buffalo 3
Cairo 3
Caltagirone 3
Fremont 3
Guidonia Montecelio 3
Lariano 3
Matera 3
Neuenstadt 3
Ottawa 3
Richmond 3
Athens 2
Biancavilla 2
Boardman 2
Cardito 2
Civitavecchia 2
Controguerra 2
Corteno Golgi 2
Duncan 2
Genoa 2
Guardavalle 2
Lappeenranta 2
Laxou 2
Los Angeles 2
Montefredane 2
Mountain View 2
Nanjing 2
Pathanamthitta 2
Phoenix 2
Plano 2
Poggibonsi 2
Pomezia 2
Rende 2
Sacramento 2
Trabzon 2
West Jordan 2
Auckland 1
Austin 1
Azcapotzalco 1
Bangalore 1
Belize City 1
Bergamo 1
Berlin 1
Buenos Aires 1
Bussolengo 1
Busto Arsizio 1
Dallas 1
Dearborn 1
Figline Valdarno 1
Florence 1
Fubine 1
Guidonia 1
Hefei 1
Hounslow 1
Jakarta 1
Jönköping 1
Las Vegas 1
London 1
Totale 1.140
Nome #
Prevention of cardiovascular disease. screening for magnesium deficiency 85
2D/3D echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy 78
Triggers for atrial fibrillation. the role of anxiety 70
Heart failure pharmacological management. gaps and current perspectives 58
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis 56
IL TRATTAMENTO DELLA FIBRILLAZIONE ATRIALE IN PRONTO SOCCORSO: L’ESPERIENZA DI UN SINGOLO CENTRO CON AMBULATORIO ARITMOLOGICO DEDICATO 55
The Choice of Antithrombotic Therapy in a Patient with New-Onset Atrial Fibrillation and High Coronary Thrombotic Risk 54
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 54
Potential role of eNOS genetic variants in ischemic heart disease susceptibility and clinical presentation 46
Ischemic heart disease and heart failure. role of coronary ion channels 44
Adverse drug reactions during real-life use of direct oral anticoagulants in italy. An update based on data from the italian national pharmacovigilance network 43
Myocardial tissue characterization in heart failure with preserved ejection fraction. from histopathology and cardiac magnetic resonance findings to therapeutic targets 43
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 42
Flecainide how and when. a practical guide in supraventricular arrhythmias 41
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease 40
Flecainide in ventricular arrhythmias. from old myths to new perspectives 40
The role of ranolazine for the treatment of residual angina beyond the percutaneous coronary revascularization 39
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak 38
Medical management of right ventricular dysfunction in pulmonary arterial hypertension 37
Ischemic heart disease pathophysiology paradigms overview. from plaque activation to microvascular dysfunction 37
Delayed efficacy of radiofrequency catheter ablation on arrhythmias originating in the interventricular basal septum 36
Electrocardiographic features, mapping and ablation of idiopathic outflow tract ventricular arrhythmias 33
Sporadic high pacing and shock impedance on remote monitoring in hybrid implantable cardioverter-defibrillator systems: clinical impact and management 33
[Leadless pacing: present and future of cardiac stimulation] 32
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation 32
Incidence of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Guided Antithrombotic Strategy 30
Prevalence and clinical Implications of COVID-19 myocarditis 28
A mobile app for improving the compliance with remote management of patients with cardiac implantable devices. a multicenter evaluation in clinical practice 28
Radiofrequency Energy Applications Targeting Significant Residual Leaks After Watchman Implantation: A Prospective, Multicenter Experience 27
Left atrial appendage exclusion in atrial fibrillation radiofrequency ablation during mitral valve surgery: a single-center experience 27
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion 26
Clinical, procedural and lead outcomes associated with different pacing techniques. a network meta-analysis 25
The scar. the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias 25
Clinical presentation, diagnosis, and treatment of atrioesophageal fistula resulting from atrial fibrillation ablation 24
Reply to the editor-high subthreshold pacing impedance from device-lead connection issues 23
Impact of COVID-19 pandemic on cardiac electronic device management and role of remote monitoring 21
The Role of MicroRNA in the myocarditis. a small actor for a great role 21
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 20
Predictive value of measures of vascular calcification burden and progression for risk of death in incident to dialysis patients 20
Catheter ablation of life-threatening ventricular arrhythmias in athletes 17
Procedural and Short-Term Follow-Up Outcomes of Amplatzer Amulet Occluder versus Watchman FLX Device: A Meta-Analysis 17
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry 15
null 15
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias 15
null 15
Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients 15
[Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?] 15
The feasibility, effectiveness and acceptance of virtual visits as compared to in-person visits among clinical electrophysiology patients during the covid-19 pandemic 14
null 14
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 14
Current approaches to worsening heart failure. pathophysiological and molecular insights 13
null 13
Hypersensitivity myocarditis after COVID-19 mRNA vaccination 12
Catheter Ablation For Papillary Muscle Arrhythmias A Systematic Review 12
Zero-Contrast Left Atrial Appendage Occlusion and Peridevice Leak Closure in Patients with Advanced Kidney Disease 10
Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients 10
Protection against ischemic heart disease. a joint role for eNOS and the KATP channel 9
Spontaneous coronary artery dissection in clinical practice. pathophysiology and therapeutic approaches 9
Telemedicine: an effective and low-cost lesson from the covid-19 pandemic for the management of heart failure patients 7
New challenges in heart failure with reduced ejection fraction. managing worsening events 6
Rationale and study design of the Italian Registry in the setting of atrial fibrillation ablation with Rivaroxaban - IRIS 4
Totale 1.782
Categoria #
all - tutte 7.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/2020123 10 7 2 6 13 9 21 20 13 9 6 7
2020/2021160 1 7 0 1 17 2 2 40 23 42 8 17
2021/2022473 11 4 25 63 42 26 12 63 50 16 89 72
2022/2023494 85 92 12 38 52 43 15 36 59 14 43 5
2023/2024521 23 55 45 60 76 103 20 41 4 57 37 0
Totale 1.782